; and (B) an assurance that the plan will focus on collaboration across health care settings and include a summary of resource gaps and challenges. (3) Authorization of appropriations There is authorized to be appropriated such sums as may be necessary to carry out this subsection. . (b) Advancing hospital reporting on antibiotic use and antimicrobial resistance Not later than 1 year after the date of enactment of this Act, the Administrator of the Centers for Medicare & Medicaid Services shall issue a notice of proposed rulemaking that requires acute care hospitals to report antibiotic use and antimicrobial resistance using the National Healthcare Safety Network’s Antimicrobial Use and Resistance Module as part of the Hospital Inpatient Quality Reporting Program. (c) In general Section 320B of the Public Health Service Act, as added by section 2 and amended by subsection (a), is further amended by adding at the end the following: (d) Promoting the appropriate use of antibiotics (1) In general Beginning on January 1, 2021, and annually thereafter, the Centers for Disease Control and Prevention shall conduct at least one antimicrobial stewardship workshop in a State or region where annual prescriptions for antimicrobial drugs per capita exceed the national average. (2) Requirements The workshop under paragraph (1) shall identify regional strategies to support collaboration across the care continuum to promote the appropriate use of antimicrobials. In implementing such workshop, the Director of the Centers for Disease Control and Prevention should seek participation from relevant public and private stakeholders with expertise in health care, quality improvement, and consumer engagement. (3) Authorization of appropriations There is authorized to be appropriated such sums as may be necessary to carry out this subsection. (e) Study on prescription drug monitoring programs (1) In general The Centers for Disease Control and Prevention shall conduct a study on the feasibility of requiring ambulatory and outpatient health